Nutranomics Receives Product Development Request from one of Southeast Asia's Largest Direct Sales Companies

Dec 02, 2013, 04:05 ET from Nutranomics, Inc.

DRAPER, Utah, Dec. 2, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to report that it has received a new product Research and Development Request from QI Group of Companies ("QI Group"), one of Southeast Asia's largest direct sales companies with revenues exceeding $800 million annually.

Based on the Research and Development Request from QI Group, Nutranomics will prepare and present a unique series of nutraceutical health food supplement products that are intended to be unveiled by QI Group for new product launches in several countries.

"We have spent many years working to develop, formulate, and test our comprehensive suite of products in accordance with the highest industry standards," stated Nutranomics CEO, Dr. Tracy K. Gibbs. "This strong product development foundation has earned Nutranomics a positive response from some of the largest and most respected direct marketing companies in the world that have built a reputation for offering only the highest-quality products to their customers. We are very happy to develop these new products for a company like QI Group that shares our commitment to quality."

Mr. Amar Chandnani, Nutranomics' Southeast Asian Markets Director, concluded, "Over the years, I have established personal relationships with many of the Board of Directors of QI Group. I look forward to the opportunity to expand upon these relationships and presenting QI Group with an exciting new line of products that will exceed their customers' expectations and complement their high-quality focused business."

Founded in 1998, QI Group has operations in direct selling and ecommerce, lifestyle and leisure, luxury and collectibles, training and education, as well as property management and logistics. QI Group has expanded its business to over 30 countries with regional offices in Hong Kong, Singapore, Malaysia, Thailand, and the Philippines. For additional information concerning the QI Group of Companies, please visit

About Nutranomics

Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.

For further information regarding Nutranomics, Inc., please contact our investor relations representatives at or call toll-free (888) 616-3999.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's ability to develop and distribute products to the QI Group of Companies. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States.  Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate.  Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

SOURCE Nutranomics, Inc.